AB-Pred

Aalborg, Denmark Founded: 2022 • Age: 4 yrs
Provides antibody prediction software for specialized applications.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About AB-Pred

AB-Pred is a company based in Aalborg (Denmark) founded in 2022 by Louis Loeb and Kenneth Kastaniegaard. It operates as a B2B. AB-Pred operates in a competitive market with competitors including Benchsci, Nona Biosciences, EPITOPIC, Deep Biologics and NatIgGs, among others.

  • Headquarter Aalborg, Denmark
  • Founders Louis Loeb, Kenneth Kastaniegaard
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of AB-Pred

Premium access

Detailed funding history for AB-Pred

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AB-Pred

Investments
Premium access

Investment portfolio details for AB-Pred

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AB-Pred

Premium access

Detailed financials for AB-Pred

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ab-Pred Comparisons

AB-Pred Primary company
Description
Provides antibody prediction software for specialized applic...
Location
Aalborg, Denmark
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for AB-Pred

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AB-Pred

AB-Pred operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benchsci, Nona Biosciences, EPITOPIC, Deep Biologics and NatIgGs, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI platform used for extracting antibody data from scientific papers.
Locked Locked Locked
Offers antibody discovery, development, and engineering services for biotherapeutics.
Locked Locked Locked
Provider of cell therapy and antibody services
Locked Locked Locked
Provider of an AI-based antibody mining and screening platform for R&D work
Locked Locked Locked
Biotech startup discovers and improves natural antibodies for brain disease treatments using AI.
Premium access

Detailed competitors of AB-Pred

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ab-Pred

Premium access

Complete news archive for AB-Pred

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AB-Pred

AB-Pred was founded in 2022.

AB-Pred is headquartered in Aalborg, Denmark.

Kenneth Kastaniegaard is the current CEO of AB-Pred. They have also founded this company.

AB-Pred, led by Louis Loeb as Co-Founder, CCO, Kenneth Kastaniegaard as Co-Founder, CEO, specializes in technology and healthcare, advancing biotech innovations, providing software for education, and antibody prediction. Provides antibody prediction software for specialized applications. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

AB-Pred's top competitors include Benchsci, Deep Biologics and EPITOPIC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available